Second carcass-eating fly species cleared by FDA for maggot wound therapy

New Type of Maggots Cleared by FDA as Medical Treatment

FDA clears Lucilia cuprina larvae (Medifly Maggots) as medical debridement product—first species of its kind for non-healing chronic wounds affecting 1-2% of population. Non-antibiotic therapy reduces amputation risk, expanding biotech alternatives to antibiotics in wound care.